Browse grants
Federal and state grant opportunities with plain-English eligibility summaries. We aggregate public records — always verify the details on the funder’s site before applying. Or browse the complete index →
Updated National Dislocated Worker Grant Program Guidance and Application Information
Due Dec 31, 2028Employment and Training Administration · $150K–$10M
This U.S. Department of Labor program provides National Dislocated Worker Grants to help communities respond to layoffs and disasters that displace workers. Eligibility is restricted to government and workforce entities such as state workforce agencies, local Workforce Development Boards, outlying areas, and Indian tribal governments, depending on the grant type; individual nonprofits and businesses are not direct applicants. Awards are large, ranging from about $150,000 up to roughly $10M.
Government / tribalLarge awardNarrow eligibilityLimited Competition: Instrumentation Grant Program for Resource-Limited Institutions (S10 - Clinical Trial Not Allowed)
Due Jan 26, 2029National Institutes of Health · $25K–$250K
This NIH S10 instrumentation grant funds resource-limited institutions to purchase state-of-the-art scientific instruments supporting biomedical research and education. It is a limited competition that invites applications only from eligible organizations, and awards range from about $25,000 to $250,000. Foreign organizations and foreign components of U.S. organizations are not eligible to apply.
Schools & universitiesResearchersNarrow eligibilityBiomedical Technology Optimization and Dissemination Center (BTOD) (RM1 - Clinical Trial Not Allowed)
Due Jan 29, 2029National Institutes of Health · Amount varies
This NIH/NIGMS RM1 grant funds Biomedical Technology Optimization and Dissemination Centers to refine late-stage research technologies and sustainably share them with the wider biomedical research community. Applicants should be leaders in their technology field and within the NIGMS mission. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components within a project may be allowed.
ResearchersSchools & universitiesNarrow eligibilityMaximizing Investigators’ Research Award (MIRA) for Early Stage Investigators (ESI)
Due Feb 6, 2029National Institutes of Health · Amount varies
This NIH/NIGMS award (MIRA for Early Stage Investigators) funds early-career biomedical researchers at U.S. institutions to run an independent research program aligned with the NIGMS mission. It is aimed at Early Stage Investigators, so it is restrictive by career stage. Non-U.S. (foreign) institutions and foreign components of U.S. organizations are not eligible to apply, though foreign components within projects may be allowed per NIH policy.
ResearchersSchools & universitiesNarrow eligibilityHEAL Initiative: Translating Addiction Epidemiology, Prevention, Treatment, and Recovery Research into Practice (R61/R33 - Clinical Trial Optional)
Due Feb 9, 2029National Institutes of Health · Amount varies
This NIH HEAL Initiative R61/R33 grant funds action-oriented research that translates addiction epidemiology, prevention, treatment, and recovery findings into practice to address the opioid crisis and overdose. Projects can target individual, provider, organizational, community, or system levels. Foreign organizations and foreign components of U.S. organizations are not eligible to apply, though foreign components within a project may be allowed.
ResearchersSchools & universitiesNarrow eligibilityHEAL Initiative: Non-addictive Analgesic Therapeutics Development [Small Molecules and Biologics] to Treat Pain (UG3/UH3 Clinical Trial Optional)
Due Feb 20, 2029National Institutes of Health · Amount varies
This NIH HEAL Initiative UG3/UH3 cooperative agreement funds preclinical optimization and development of safe, non-addictive small-molecule and biologic therapeutics for treating pain, advancing candidates toward Phase II trials. Applicants must already have a promising lead candidate, a strong biological rationale, and established assays. Foreign organizations and foreign components of U.S. organizations are not eligible to apply.
ResearchersSmall businessSchools & universitiesNarrow eligibilityF24AS00298 Cooperative Agriculture
Due Mar 7, 2029Fish and Wildlife Service · Amount varies
The U.S. Fish and Wildlife Service offers Cooperative Agriculture Agreements that let private individuals or small businesses farm, hay, or graze on National Wildlife Refuge lands in support of conservation objectives. This is a non-financial program: no federal funds are awarded, and arrangements are cost-sharing or in-kind (labor, equipment, crop yield) and may involve bids or payments to the Service. Pre-application coordination is required, and only private individuals or small business entities are eligible.
Small businessIndividualsCost-share requiredNarrow eligibilityPaul Calabresi Career Development Award for Clinical Oncology (K12 Clinical Trial Not Allowed)
Due Mar 12, 2029National Institutes of Health · Amount varies
This NIH (K12) career development award supports institutions in training clinician-scientists for clinical and translational cancer research. It is an institutional mentored program; scholars may gain experience in a mentor-led clinical trial but may not lead an independent clinical trial. Only domestic U.S. organizations may apply, foreign organizations are not eligible, though foreign components are allowed. It primarily suits academic medical centers and research institutions building oncology research careers.
Schools & universitiesResearchersNarrow eligibilityMathematical Sciences Research Institutes
Due Mar 14, 2029U.S. National Science Foundation · $1.5M–$6.5M
This National Science Foundation program funds Mathematical Sciences Research Institutes as national resources that advance research in mathematics and statistics and broaden participation, with awards ranging roughly from $1.5 million to $6.5 million. Only U.S.-based non-profit non-academic research organizations and accredited institutions of higher education may apply; multi-institutional consortia are allowed but one entity must take overall management responsibility. Individuals and for-profit firms are not eligible.
Schools & universitiesNonprofitsResearchersLarge award+1 moreNIH Small Business Innovation Research (SBIR) Phase IIB Strategic Breakthrough Award (Parent [R44] Clinical Trial Optional)
Due Apr 5, 2029National Institutes of Health · Amount varies
This NIH SBIR Phase IIB award is restricted to U.S. small business concerns that have previously received an NIH SBIR or STTR Phase II award; it bridges the gap between Phase II and commercialization for later-stage R&D. Only one such award is allowed per project, and applications must be submitted within the first six due dates after the Phase II budget period ends, so it is narrow and limited to existing grantees. Foreign organizations are not eligible to apply.
Small businessNarrow eligibilitySBIR/STTR Commercialization Readiness Pilot (CRP) Program (Parent SB1 Clinical Trial Optional)
Due Apr 5, 2029National Institutes of Health · Amount varies
This NIH SBIR/STTR Commercialization Readiness Pilot (CRP) is restricted to U.S. small business concerns (as defined by the SBA) and helps move NIH-funded SBIR/STTR projects from late-stage development toward commercialization. It supports later-stage R&D and technical assistance such as replication studies, IND/IDE-enabling work, clinical studies, manufacturing scale-up, and regulatory support, and a significant portion may be subcontracted. Foreign organizations are not eligible to apply.
Small businessNarrow eligibilityPredoctoral to Postdoctoral Transition Award (Parent F99/K00 - Clinical Trial Not Allowed)
Due Apr 8, 2029National Institutes of Health · Amount varies
This NIH Predoctoral-to-Postdoctoral Transition Award (F99/K00) supports promising graduate students as they finish doctoral research and move into mentored postdoctoral career development, in NIH mission-relevant fields. It is a mentored training award administered through institutions; candidates may not lead an independent clinical trial but may participate in a sponsor-led one. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed.
Schools & universitiesResearchersNarrow eligibilityNIH Research Educational Program - Mentoring Activities & Networks (Parent R25/UE5 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25/UE5) funds mentoring activities and networks that develop the biomedical, behavioral, and clinical research workforce. It requires institutional commitment of staff, facilities, and resources, and proposed activities must be distinct from any existing federally funded training programs (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Research Experiences (Parent R25 - Clinical Trial Not Allowed)
Due May 5, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds hands-on research experiences that help build and diversify the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can provide the staff, facilities, and educational resources to run such programs, and proposed activities must be distinct from any existing federally funded training grants (such as T32). Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIH Collaborative International Research Project (Parent PF5 Clinical Trial Optional)
Due May 7, 2029National Institutes of Health · Amount varies
This NIH parent opportunity supports research projects built around international collaborations between a U.S. (domestic prime) organization and foreign partners, and at least one international subproject is required. Only domestic U.S. organizations may apply as the prime; non-U.S. entities cannot apply directly, though funded foreign components are allowed. It is aimed at research institutions and universities pursuing health-related projects that need talent, populations, or resources found in other countries. Applicants should expect to manage a linked prime-and-foreign-subaward structure.
Schools & universitiesResearchersNarrow eligibilityBiological Testing Facility for Contraception & Reproductive Health (X01 Clinical Trial Not Allowed)
Due May 7, 2029National Institutes of Health · Amount varies
This NIH (X01) opportunity does not provide cash funding but instead grants investigators access to services from a state-of-the-art Biological Testing Facility to advance contraceptive development or reproductive health research. Applicants do not need current NIH funding, though priority may go to programs already receiving NIH support. Notably, foreign organizations are eligible to apply, but foreign components of U.S. organizations and foreign components in general are not allowed. It suits researchers needing specialized biological testing resources.
ResearchersSchools & universitiesNarrow eligibilityNIAID Investigator Initiated Program Project Applications (P01 Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH/NIAID Program Project (P01) opportunity funds multi-component research programs in infectious disease and immunology, including HIV, immune dysfunction, allergy, autoimmunity, and vaccine/therapeutic/diagnostic development. Each application must include at least two related research projects plus an administrative core, so it is geared toward research institutions with established teams. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed. Clinical trials are not permitted under this NOFO.
Schools & universitiesResearchersNarrow eligibilityNIH Research Education Program - Courses, Curriculum & Methods (Parent R25 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH Research Education Program (R25) funds the development of courses, curricula, and educational methods that strengthen the biomedical, behavioral, and clinical research workforce. It is aimed at institutions that can commit staff, facilities, and educational resources, and proposed activities must be distinct from any existing federally funded training grants (such as T32) at the applicant. Only domestic U.S. organizations may apply; foreign organizations are not eligible and foreign components are not allowed. Clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityNIAID Resource-Related Research Projects (R24 Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH/NIAID Resource-Related Research Project (R24) opportunity funds the creation or support of shared scientific resources that benefit high-priority research in infectious disease and immunology. NIAID expects to use it infrequently, only when other funding mechanisms are not appropriate, so it is a narrow opportunity for research institutions. Only domestic U.S. organizations may apply; foreign organizations are not eligible, though foreign components are allowed, and clinical trials are not permitted.
Schools & universitiesResearchersNarrow eligibilityLimited Competition: Centers of Biomedical Research Excellence: Expansion/Sustainability Phases (COBRE-E/S) (P30 - Clinical Trial Not Allowed)
Due May 25, 2029National Institutes of Health · Amount varies
This NIH award is open only to U.S. institutions located in IDeA-eligible states/jurisdictions (a fixed list including Alaska, Arkansas, Delaware, Hawaii, Kentucky, Mississippi and others) that grant doctoral degrees in health-related sciences or are NIH-funded biomedical research institutes. It funds the expansion and sustainability of existing Centers of Biomedical Research Excellence, building faculty, research projects, and core facilities. Eligibility is narrow: it is a limited competition by invitation, applicants may hold no more than three active COBRE awards, and foreign organizations and foreign components are not eligible.
Schools & universitiesResearchersNarrow eligibility